Search results for: 'nanoparticle monitor'

The Thai contact center applications market size is estimated to grow from $16.4 million in 2016 to $27.1 million by 2023, at a Compound Annual Growth Rate (CAGR) of 7.4%. The research service is part of the Asia-Pacific market tracker for the contact center applications market, which covers 14 countries (Australia, China, Hong Kong, India, Indone...

09 May 2018  |  Asia Pacific  |  Market Research

Asia-Pacific Contact Center Applications Market, Forecast to 2023

Moderate Growth is Expected, as Investment Will Shift from Core Application Segments

Infographics

×

Key Issues Addressed

The Asia-Pacific (APAC) contact center applications market size is estimated to grow from $647.1 million in 2016 to $733.1 million by 2023, at a Compound Annual Growth Rate (CAGR) of 1.8%. The research service covers the contact center applications market across 14 countries (Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, New Zeala...

21 Jun 2018  |  North America  |  Market Research

Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022

Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations

Infographics

×

Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...

17 Aug 2018  |  Global  |  Market Research

Electronic Test and Measurement Market, Forecast to 2022

5G, Autonomous Driving, Power Management Applications, High-speed Digital Technologies and Data Centers Spur Growth

Infographics

×

Key Issues Addressed

Used for the development and manufacturing of products across industries, deployment of networks, and maintenance of services, electronic test and measurement (T&M) equipment are witnessing increasing demand due to the proliferation of electronics and emerging disruptive concepts such as 5G and autonomous driving. With the smart mobility concept an...

30 Oct 2018  |  Global  |  Market Research

Global Communications Test and Measurement Market, Forecast to 2022

Digitization and Virtualization are the Key Enablers That Drive the Market; But Tight CAPEX Budgets Challenge Growth

Infographics

×

Key Issues Addressed

The high demand for data and lower latency from applications such as video streaming, financial trading, Internet of Things (IoT), connected cars, Big Data, and data analytics is requiring advancements in network devices and infrastructure. The Test and Measurement (T&M) market in communications is thus, driven by the need to test and validate the...

Environmental concerns are compelling governments and companies to switch to a green manufacturing model. Manufacturers across various sectors may have different motivations to adopt sustainable practices; for some, it could be complying with government regulations, while for others, it could be to build a green label and gain customer loyalty or i...

This Frost Radar™ provides an in-depth analysis of 15 of the top Growth and Innovation leaders offering digital signage software and services. Digital signage has evolved beyond the static board or wall to become a dynamic and adaptable communication medium that fits within omnichannel marketing and enterprise communication strategies and toolsets....

The COVID-19 pandemic disrupted global supply chains, which still struggle with unpredictable shipment delays and longer harbor freight holdups on top of inefficient planning, higher costs, and lack of real-time visibility. The transportation management system (TMS) market is on growth trajectory as more companies realize the potential to reduce tr...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...